Dr. Peter Anderson
Dr. Peter Andersen is currently Vice President of Vaccine Research and Development at Statens Serum Institut in Copenhagen, Denmark, a highly recognized international research institution whose goal is to control and prevent the spread of infectious diseases and biological threats. Dr. Andersen brings exceptional expertise to Chembio's ongoing efforts to develop a rapid diagnostic test for Tuberculosis (TB). His research has focused on the identification and characterization of novel antigens and immune mechanisms for protection against TB. Dr. Anderson has over 100 keynote presentations and papers to his credit.
